TREAT Medspa（New York, NY）

TREAT Medspa operates in New York, NY under the medical direction of Dr. Fiona Gupta, combining aesthetic medicine with evidence-based weight management protocols. The practice integrates Semaglutide therapy into comprehensive body transformation programs that address both metabolic health and aesthetic goals. Dr. Gupta’s approach recognizes that sustainable weight loss often requires medical intervention alongside cosmetic procedures, creating treatment plans that support patients through multiple phases of physical transformation.

The clinic’s Semaglutide program follows FDA-approved dosing protocols for weight management, with patients receiving weekly subcutaneous injections that reduce appetite and improve glycemic control. Dr. Gupta conducts initial metabolic assessments including body composition analysis, thyroid function testing, and cardiovascular screening before initiating peptide therapy. Patients typically begin with 0.25mg weekly doses, with gradual titration based on tolerance and weight loss response over 16-20 week treatment cycles. The medical team monitors patients for common side effects including nausea and gastrointestinal changes, adjusting protocols to maintain both efficacy and comfort. TREAT Medspa pairs Semaglutide therapy with body contouring consultations, allowing patients to address both weight reduction and skin laxity that may result from significant fat loss.

Dr. Gupta brings aesthetic medicine expertise to her weight management protocols, understanding how facial volume loss and skin texture changes accompany metabolic shifts. The practice offers neuromodulator treatments and dermal fillers to address facial aging that becomes more apparent during weight loss phases. Laser treatments available at the New York location include skin tightening modalities that complement peptide-induced fat reduction. The clinic’s skincare protocols incorporate medical-grade products that support skin barrier function during metabolic changes, addressing the dermatologic effects of GLP-1 receptor agonist therapy that some patients experience.

Patients schedule in-person consultations at the New York medspa location, where Dr. Gupta reviews medical history, current medications, and aesthetic concerns before recommending treatment combinations. Initial Semaglutide consultations include discussion of realistic weight loss timelines, with most patients losing 10-15% of body weight over 6-month treatment periods. The practice provides detailed injection training during first appointments, though many patients opt for in-office administration throughout their treatment course. Follow-up visits occur every 4 weeks during dose escalation phases, with Dr. Gupta adjusting treatment intensity based on weight loss velocity and side effect profiles. The clinic’s aesthetic services allow patients to address body contouring needs, facial volume restoration, and skin quality improvements as their weight stabilizes.

TREAT Medspa’s New York location serves Manhattan residents seeking medical weight loss integrated with comprehensive aesthetic care. The practice maintains in-person service exclusively, with no telehealth options for peptide prescribing or monitoring. Dr. Gupta’s dual focus on metabolic health and aesthetic outcomes distinguishes the clinic from weight loss programs that ignore the cosmetic implications of significant fat reduction. Patients benefit from coordinated care that anticipates the facial and body changes accompanying GLP-1 therapy, with treatment plans that evolve as weight loss progresses. The clinic’s 5.0-star rating across 39 Google reviews reflects patient satisfaction with both clinical outcomes and the integrated approach to body transformation that addresses medical, aesthetic, and dermatologic dimensions of weight management.